JDS Therapeutics LLC and its subsidiary Nutrition 21, LLC reported that they have entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research, Inc.
The settlement ends a patent and trademark infringement lawsuit brought by Nutrition 21 against SuperNutrition in the Southern District of New York related to SuperNutrition’s use of Nutrition 21′s Chromax trademark and chromium polynicotinate in their branded multivitamin products, reported Nutrition 21.
Gregg Bresner, CEO, Nutrition 21, said the company is delighted that it reached a customer-driven solution with respect to the SuperNutrition dispute.
“SuperNutrition has been an innovative company in the market for decades and we are excited to provide Niachrome to SuperNutrition for use in its branded family of multivitamin products,” said Bresner. “We believe this reaffirms the strength of Nutrition 21′s trademarks, and its patent portfolio which covers compositions and uses of a number of our products, including our Niachrome chromium polynicotinate.”
Though the settlement terms are confidential, SuperNutrition has agreed to license Nutrition 21’s various chromium polynicotinate patents and its Chromax and Niachrome trademarks, while also utilizing Nutrition 21′s Niachrome brand of chromium polynicotinate for applicable formulation needs, reported Nutrition 21.
For more information visit www.nutrition21.com.